Omeros (OMER) Net Cash Flow (QoQ) (2010 - 2026)
Omeros (OMER) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Omeros |
737.87 Mn |
602.55 Mn |
9.31 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-206.73% |
| Dec 31, 2025 |
1,318.95% |
| Sep 30, 2025 |
121.53% |
| Jun 30, 2025 |
-376.19% |
| Mar 31, 2025 |
-54.18% |
| Dec 31, 2024 |
413.69% |
| Sep 30, 2024 |
-307.27% |
| Jun 30, 2024 |
105.48% |
| Mar 31, 2024 |
77.59% |
| Dec 31, 2023 |
-197.91% |
| Sep 30, 2023 |
766.51% |
| Jun 30, 2023 |
138.64% |
| Mar 31, 2023 |
94.66% |
| Dec 31, 2022 |
-202.38% |
| Sep 30, 2022 |
2,440.05% |
| Jun 30, 2022 |
105.63% |
| Mar 31, 2022 |
-198.34% |
| Dec 31, 2021 |
1,866.46% |
| Sep 30, 2021 |
-243.90% |
| Jun 30, 2021 |
349.42% |
